Company Filing History:
Years Active: 2013
Title: Alvaro Rendon: Innovator in Angiogenesis Modulation
Introduction
Alvaro Rendon is a prominent inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the modulation of angiogenesis. His innovative work has the potential to impact therapeutic approaches for various medical conditions.
Latest Patents
Alvaro Rendon holds a patent titled "Methods for modulating angiogenesis via dystrophin Dp71." This invention relates to methods and compositions for inhibiting or stimulating angiogenesis. The invention highlights the role of Dp71 in angiogenesis and provides novel therapeutic approaches. It also introduces methods for screening agents that modulate angiogenesis, specifically targeting this protein. The patent outlines the use of Dp71 or its variants for stimulating angiogenesis in subjects, particularly humans, and discusses the use of Dp71 inhibitors for inhibiting angiogenesis.
Career Highlights
Alvaro Rendon is affiliated with the Institut National de la Santé et de la Recherche Médicale, where he conducts his research. His work has garnered attention for its innovative approach to understanding and manipulating angiogenesis, which is crucial for various physiological and pathological processes.
Collaborations
Alvaro has collaborated with notable colleagues, including Romain Bernard and Bénédicte Dupas. These collaborations have further enriched his research and contributed to advancements in the field.
Conclusion
Alvaro Rendon's contributions to the field of angiogenesis modulation through his innovative patent demonstrate his commitment to advancing medical research. His work holds promise for developing new therapeutic strategies that could benefit many patients in the future.